Почетна › Затајење срца › Misuri
Kliničke studije za Затајење срца u državi Misuri
40 studija za Затајење срца traži učesnike na lokacijama u državi Misuri.
Gradovi u državi Misuri
Zvanični tekst studije (na engleskom)
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Washington University-Pediatric Cardiology/ St. Louis Children's Hospital ( Site 0006), St Louis
Тражи се учесникФаза 2/3
29 Days – 17 Years · Оба пола · Ажурирано 13. 11. 2026. · NCT05714085A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Kansas City VA Medical Center, Kansas City
- North Kansas City Hospital, North Kansas City
- St. Louis Heart and Vascular, P.C., St Louis
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06424288A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Kansas City VA Medical Center, Kansas City
- St. Louis Heart and Vascular, P.C., St Louis
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06935370INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
- Barnes Jewish, St Louis
Тражи се учесник
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 11. 2026. · NCT06965504Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
- Saint Luke's Hospital of Kansas City, Kansas City
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07232030Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- St. Luke's Hospital, Kansas City
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06526195Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Columbia
- Kansas City
- St Louis
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 4. 11. 2026. · NCT00271180A Study of LY3971297 in Participants With Heart Failure
- Washington University, St Louis
Тражи се учесникФаза 1
Узраст од 18 до 65 · Оба пола · Ажурирано 4. 11. 2026. · NCT07547540Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Saint Luke's Hospital of Kansas City, Kansas City
- Washington University Center for Advanced Medicine, St Louis
Тражи се учесникФаза 3
Узраст од 18 до 85 · Оба пола · Ажурирано 4. 11. 2026. · NCT06736574ELEVATE-HFpEF Clinical Study
- Saint Lukes Mid America Heart Institute, Kansas City
Тражи се учесник
Узраст 40 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06678841Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Saint Luke's Hospital of Kansas City, Kansas City
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 29. 10. 2026. · NCT07037459A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Children's Mercy Hospital Kansas City - Cardiology, Kansas City
- Washington University - St. Louis Children's Hospital - Cardiology, St Louis
Тражи се учесникФаза 3
До 18 година · Оба пола · Ажурирано 27. 10. 2026. · NCT07192952CCM OPEN HF Registry
- Saint Luke's Hospital Mid America Heart Institute, Kansas City
- Saint Luke's Hospital of Kansas City, Kansas City
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT07112924Assessment of CCM in HF With Higher Ejection Fraction
- St. Lukes Hospital Kansas City (Mid America Heart Institute), Kansas City
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT05064709Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Columbia
- Research Site, Kansas City
- Research Site, Kansas City
- и још 1
Тражи се учесникФаза 3
Узраст 40 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT06677060The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
- St. Luke's Hospital of Kansas City, Kansas City
Тражи се учесникОпсервациона студија
Узраст 22 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT07098858NORM-HF Pivotal Study
- Saint Luke's Hospital of Kansas City, Kansas City
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT07574593A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Children's Mercy Hospital Kansas City - Cardiology, Kansas City
- Washington University - St. Louis Children's Hospital - Cardiology, St Louis
Тражи се учесникФаза 3
6 Months – 17 Years · Оба пола · Ажурирано 15. 10. 2026. · NCT07188805A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
- Local Institution - 11, Kansas City
- Local Institution - 12, St Louis
Тражи се учесникФаза 2
Узраст од 30 до 84 · Оба пола · Ажурирано 13. 10. 2026. · NCT07795814Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Columbia
- Research Site, Kansas City
- Research Site, Kansas City
Тражи се учесникФаза 3
Узраст од 18 до 130 · Оба пола · Ажурирано 13. 10. 2026. · NCT06307652Alleviant ALLAY-HFrEF Study
- Washington University - St Louis, St Louis
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT06812533A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- Washington University School of Medicine, St Louis
Тражи се учесникФаза 2
Узраст од 40 до 84 · Оба пола · Ажурирано 5. 10. 2026. · NCT06979362A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Bridgeton
- Research Site, Kansas City
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT07761117A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- CON-10002 Kansas City, MO Investigative Site, Kansas City
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 9. 2026. · NCT06024746A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Kansas City, MO Investigative Site 10002, Kansas City
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 9. 2026. · NCT06008197AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
- Washington University Center for Advanced Medicine, St Louis
Тражи се учесникФаза 2
Узраст од 40 до 85 · Оба пола · Ажурирано 27. 8. 2026. · NCT06793371A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- St. Luke's Mid-America Heart Institute, Kansas City
- Washington University, St Louis
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 19. 8. 2026. · NCT05489705A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Clinical Research Consultants, JCCT Co, Kansas City
- Washington University, St Louis
- Amicis Centers of Clinical Research, St Louis
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT07567001Alleviant ALLAY-HF Study
- Washington University - St Louis, St Louis
Тражи се учесник
Узраст 40 и старији · Оба пола · Ажурирано 14. 8. 2026. · NCT05685303Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- Washington Univ School Of Medicine, St Louis
Тражи се учесникФаза 3
Узраст од 2 до 11 · Оба пола · Ажурирано 24. 7. 2026. · NCT06597006A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- FIN-10002 Kansas City, MO Investigational Site, Kansas City
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 7. 2026. · NCT06033950PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- St. Lukes/ Mid-American Heart Institute, Kansas City
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 29. 6. 2026. · NCT05934487Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
- University of Missouri-Columbia, Columbia
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 18 до 100 · Оба пола · Ажурирано 7. 5. 2026. · NCT07083557The Inorganic Nitrate and eXercise Performance in Heart Failure (iNIX-HF)
- Washington University School of Medicine, St Louis
Тражи се учесникФаза 2
Узраст од 19 до 79 · Оба пола · Ажурирано 6. 5. 2026. · NCT05562167The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- St. Louis Heart and Vascular, St Louis
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 13. 4. 2026. · NCT03142152Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- Washington University, St Louis
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 24. 3. 2026. · NCT06217302XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
- Washington University - Barnes Jewish Health Hospital, St Louis
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 18. 3. 2026. · NCT06895070Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
- University of Mossouri, Columbia
Тражи се учесникФаза 4
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2025. · NCT06964464HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
- Saint Luke's Health System, Kansas City
Тражи се учесникОпсервациона студија
Узраст од 18 до 100 · Оба пола · Ажурирано 22. 5. 2024. · NCT06425848Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
- Washington University in Saint Louis, St Louis
Тражи се учесникФаза 1/2
Узраст од 18 до 80 · Оба пола · Ажурирано 26. 3. 2024. · NCT04703842Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.